Mallinckrodt Public Limited Company - 6 Year Stock Split History | MNK

Stock split history for Mallinckrodt Public Limited Company since 2013. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Mallinckrodt Public Limited Company Annual Stock Splits
Mallinckrodt Public Limited Company Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.706B $3.216B
Mallinckrodt Plc. is engaged in pharmaceuticals business. It develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company's Specialty Pharmaceuticals segment includes branded and generic drugs and Medical Imaging segment includes contrast media and nuclear imaging agents. Mallinckrodt Plc. is based in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $42.473B 7.74
Mylan (MYL) United Kingdom $9.258B 4.05
Teva Pharmaceutical Industries (TEVA) Israel $8.389B 3.29
Bausch Health Cos (BHC) Canada $8.361B 5.71
Dr Reddy's Laboratories (RDY) India $5.991B 22.41
Supernus Pharmaceuticals (SUPN) United States $1.571B 15.70
Amphastar Pharmaceuticals (AMPH) United States $0.952B 53.21
Voyager Therapeutics (VYGR) United States $0.948B 0.00
Homology Medicines (FIXX) United States $0.800B 0.00
Akorn (AKRX) United States $0.595B 0.00
CymaBay Therapeutics (CBAY) United States $0.465B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.442B 0.00
Assembly Biosciences (ASMB) United States $0.330B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.274B 0.00
Sol-Gel Technologies (SLGL) Israel $0.169B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.159B 0.00
Acasti Pharma (ACST) Canada $0.080B 0.00
Agile Therapeutics (AGRX) United States $0.063B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.056B 0.00
Teligent (TLGT) United States $0.030B 0.00
Evoke Pharma (EVOK) United States $0.014B 0.00
China Pharma Holdings (CPHI) China $0.013B 0.00
Aevi Genomic Medicine (GNMX) United States $0.012B 0.00